DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Huober J, Fasching P, Paepke S. et al
Letrozole in combination with trastuzumab is superior to letrozole monotherapy as first line treatment in patients with hormone-receptor-positive, HER2-positive metastatic breast cancer (MBC) – results of the eLEcTRA trial.
Cancer Res 2009;
69 (24, suppl) ;doi:
DOI: 10.1158/0008-5472.SABCS-09-4094.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.